Fig. 4: Univariate analysis revealed multiple comorbidities that influence OS.
From: Medical comorbidities prognosticate survival in glioblastoma
Hypertension (a), hyperlipidemia (b), diabetes (d), atrial fibrillation (e), stroke (f), Chronic Obstructive Pulmonary Disease (COPD) (g), and additional malignancy (h) all had a statistically significant influence on glioblastoma patient survival, while obesity (c) did not. Patients without Body Mass Index (BMI) data were excluded from obesity survival analysis (n = 201). mOS and respective 95% CI for all comorbidities are listed in Supplementary Table 4.
